HK1099211A1 - Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides - Google Patents

Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

Info

Publication number
HK1099211A1
HK1099211A1 HK07105470.1A HK07105470A HK1099211A1 HK 1099211 A1 HK1099211 A1 HK 1099211A1 HK 07105470 A HK07105470 A HK 07105470A HK 1099211 A1 HK1099211 A1 HK 1099211A1
Authority
HK
Hong Kong
Prior art keywords
dimethylisosorbide
pimecrolimus
composition containing
medium chain
hexylene glycol
Prior art date
Application number
HK07105470.1A
Other languages
English (en)
Inventor
Meir Eini
Doron Friedman
Stefan Hirsch
Sabine Meyenburg
Nabila Sekkat
Dov Tamarkin
Original Assignee
Meda Pharma S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0408076A external-priority patent/GB0408076D0/en
Priority claimed from GB0408070A external-priority patent/GB0408070D0/en
Application filed by Meda Pharma S A R L filed Critical Meda Pharma S A R L
Publication of HK1099211A1 publication Critical patent/HK1099211A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07105470.1A 2004-04-08 2007-05-23 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides HK1099211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0408076A GB0408076D0 (en) 2004-04-08 2004-04-08 Pharmaceutical formulations
GB0408070A GB0408070D0 (en) 2004-04-08 2004-04-08 Pharmaceutical formulations
PCT/EP2005/003669 WO2005097068A1 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

Publications (1)

Publication Number Publication Date
HK1099211A1 true HK1099211A1 (en) 2007-08-10

Family

ID=34964902

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105470.1A HK1099211A1 (en) 2004-04-08 2007-05-23 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

Country Status (16)

Country Link
US (1) US9168224B2 (ja)
EP (1) EP1734927B8 (ja)
JP (1) JP5021456B2 (ja)
KR (1) KR101239446B1 (ja)
AU (1) AU2005230401B2 (ja)
BR (1) BRPI0509708B8 (ja)
CA (1) CA2556993C (ja)
CY (1) CY1113060T1 (ja)
DK (1) DK1734927T3 (ja)
ES (1) ES2389443T3 (ja)
HK (1) HK1099211A1 (ja)
PL (1) PL1734927T3 (ja)
PT (1) PT1734927E (ja)
RU (1) RU2375044C2 (ja)
SI (1) SI1734927T1 (ja)
WO (1) WO2005097068A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8211449B2 (en) 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
CA2610662A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9149658B2 (en) 2010-08-02 2015-10-06 Guided Therapy Systems, Llc Systems and methods for ultrasound treatment
WO2015021382A2 (en) 2013-08-08 2015-02-12 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2198582A (en) * 1937-10-01 1940-04-23 Dow Chemical Co Ether esters of para hydroxy benzoic acid
US3244589A (en) * 1962-10-26 1966-04-05 Sunnen Alkyl phenoxy polyethoxy ether spermicidal aerosol
AU565146B2 (en) * 1983-10-24 1987-09-03 Connetics Australia Pty Ltd Foamable biocide composition
US5679324A (en) * 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
EP0786986B1 (en) * 1994-10-26 2002-03-20 Novartis AG Use of an unsaturated fatty alcohol
JPH10114659A (ja) * 1996-10-11 1998-05-06 Nippon Fine Chem Co Ltd 皮膚外用剤
JPH11199444A (ja) * 1998-01-09 1999-07-27 Cosmo Products Kk 白髪の予防・治療剤
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6440437B1 (en) * 2000-01-24 2002-08-27 Kimberly-Clark Worldwide, Inc. Wet wipes having skin health benefits
JP2001097848A (ja) * 1999-09-30 2001-04-10 Kobayashi Pharmaceut Co Ltd 外用剤組成物
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
GB0108498D0 (en) 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
GB0218996D0 (en) 2002-08-14 2002-09-25 Novartis Ag Organic compounds
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam

Also Published As

Publication number Publication date
EP1734927A1 (en) 2006-12-27
AU2005230401A1 (en) 2005-10-20
EP1734927B8 (en) 2013-10-23
JP2007532508A (ja) 2007-11-15
BRPI0509708B8 (pt) 2021-05-25
KR20070024507A (ko) 2007-03-02
CY1113060T1 (el) 2016-04-13
US20080181854A1 (en) 2008-07-31
PT1734927E (pt) 2012-09-05
ES2389443T3 (es) 2012-10-26
RU2006138998A (ru) 2008-05-20
WO2005097068A1 (en) 2005-10-20
US9168224B2 (en) 2015-10-27
AU2005230401B2 (en) 2008-11-27
RU2375044C2 (ru) 2009-12-10
BRPI0509708B1 (pt) 2018-12-04
DK1734927T3 (da) 2012-09-24
EP1734927B1 (en) 2012-06-13
JP5021456B2 (ja) 2012-09-05
PL1734927T3 (pl) 2012-10-31
KR101239446B1 (ko) 2013-03-06
SI1734927T1 (sl) 2012-09-28
CA2556993A1 (en) 2005-10-20
BRPI0509708A (pt) 2007-09-18
CA2556993C (en) 2013-05-21

Similar Documents

Publication Publication Date Title
HK1099211A1 (en) Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
ZA200509760B (en) Composition for maintaining organ and cell viability
GB2429717B (en) Cell preservation method
EP1718307A4 (en) IMMUNE REPRESENTING COMPOUNDS AND COMPOSITIONS
EP1969456A4 (en) APPARATUS FOR SEARCHING AND NAVIGATING A MOBILE DEVICE
HUE037643T2 (hu) Visszaélésre nem alkalmas gyógyszerkészítmények
PL1765239T3 (pl) Struktura warstwy chłonnej
EP1718604A4 (en) COMPOUNDS AND COMPOSITIONS OF IMMUNOSUPPRESSANTS
AP2188A (en) Substituted quinolines and their use as mycobacterial inhibitors.
ZA200701527B (en) Composition comprising statin
ZA200608311B (en) Composition comprising statins
EP1737926A4 (en) GROWTH ENVIRONMENT
GB2422287B (en) Preservative and embalming fluids
EP1817110A4 (en) METHOD AND APPARATUS FOR STORING MICROPLATES
EP1786894A4 (en) DEVICE AND METHOD FOR PREVENTING DEGRADATION OF CULTURE MEDIA
EP1727635A4 (en) PRIVACY FILM FOR PRIVACY
EP1627634A4 (en) COMPOSITION FOR REDUCING THE RATE OF BODY LIPIDS
GB0514922D0 (en) Slide bearing layer
EP1730095A4 (en) NEW CYCLOPENTENDION COMPOUNDS ACTING AGAINST MUSHROOMS AND METHOD FOR THEIR APPLICATION
ZA200702966B (en) Cryopreservation of cells
EP1795572A4 (en) COMPOSITION OF INTERIOR OLEFIN AND THE BASE OIL FOR OIL HOLES CONTAINING THEM
DE112005001402A5 (de) Kanallager
HK1103987A1 (en) Propagation agent and propagation method for natural killer cell
GB0422570D0 (en) Device with storage medium and method of operating the device
GB0700613D0 (en) Chanel management using preamble containing frequencyuse information

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220407